Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. AC (Adriamycin® + Cyclo­phospha­mide) followed by THP (Taxol® + Herceptin® + Pertu­zumab) is a Chemotherapy Regimen for Breast Cancer - early stage. How does AC-THP work? Doxorubicin, cyclophosphamide, and paclitaxel are chemotherapy drugs designed to kill or slow the growth of cancer cells.

    • Early Stage

      Other risk factors for breast cancer include family history...

  2. 3 Δεκ 2020 · Among 984 cases of breast cancer during pregnancy, an increased risk of stillbirth assessed as small gestational age, preterm delivery, and neonatal mortality largely caused by iatrogenic preterm birth was reported; thus, careful monitoring on fetal growth and decisions on the timing of the delivery, aiming to a full term delivery, are critical ...

  3. Fortunately, the diagnosis of breast cancer during pregnancy is uncommon; however, such women require a tailored approach to treatment with careful consideration given at all stages to the needs of the mother and risks to the foetus.

  4. 10 Αυγ 2023 · In the shared decision-making process, we need to integrate multifaceted information, including cancer stage and relapse risk, weeks of pregnancy and the patient’s desire to bear children, and use it to examine viable treatment options (V).

  5. Systemic treatment with chemotherapy during the first trimester is associated with a high risk of miscarriage and in some cases congenital malformations, this being the period of organogenesis. The situation is less problematic when treatments are initiated in the second trimester.

  6. Breast feeding. PRESCRIPTIVE AUTHORITY: The treatment plan must be initiated by a Consultant Medical Oncologist. TESTS: Baseline tests: FBC, renal and liver profile. ECG. MUGA or ECHO (LVEF > 50% to administer DOXOrubicin) if >65 years or if clinically indicated. Regular tests: FBC, renal and liver profile .

  7. 8 Οκτ 2014 · Although 90% of women are diagnosed with early breast cancer, prospective studies have shown breast cancer–specific mortality rates exceeding 50% at 30-year follow-up in women treated with surgery alone. 3 Although local therapies can eradicate disease in the breast and axilla, early systemic dissemination of microscopic disease often precedes l...